Rosuvastatin Calcium Tablet, Film Coated
Product Images NDC 51655-458

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Rosuvastatin Calcium (NDC 51655-458). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 458 52 Rev A 05 23)

Label (51655 458 52   Rev A 05 23)
Label for Rosuvastatin Tablets, USP 5 mg, film-coated tablets, in a pack of 30. The label states it is prescription only and includes storage instructions at 20°-25°C (68°-77°F). Manufactured by Northwind Pharmaceuticals and repackaged by Northwind Health Company, LLC. The product NDC is 51655-458-52.*
FDA Label Image

Figure1 (Figure1)

Figure1 (Figure1)
A Kaplan-Meier curve showing cumulative incidence percentage over a period of 5 years comparing Rosuvastatin (ROSUVA) and placebo groups. The chart includes hazard ratio (HR 0.56, 95% CI 0.46-0.69, P < 0.001) and a risk table indicating the number of participants at risk in each group over time.*
FDA Label Image

Figure2 (Figure2)

Figure2 (Figure2)
A data table summarizing clinical event rates comparing Rosuvastatin calcium 20 mg with placebo 20 mg across several endpoints. It lists the number and rate of events per 1000-patient years for primary endpoints, cardiovascular death, nonfatal stroke, nonfatal myocardial infarction, hospitalized unstable angina, and arterial revascularization. Hazard ratios with 95% confidence intervals and P values are shown alongside a graphical hazard ratio plot.*
FDA Label Image

Figure3 (Figure3)

Figure3 (Figure3)
A box plot graph comparing the percent change from baseline in LDL-C levels for four statin drugs—Rosuvastatin, Atorvastatin, Simvastatin, and Pravastatin—at various dosages. The x-axis lists drugs and doses in milligrams, while the y-axis shows percent change, ranging from 0 to -75%. Each drug's data is depicted with box plots indicating variability in LDL-C reduction across doses.*
FDA Label Image
FDA Label Image

Logo1 (Logo1)

FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of rosuvastatin calcium showing molecular arrangement and functional groups, including aromatic rings, hydroxyl groups, and calcium ions. The diagram represents the active ingredient rosuvastatin calcium.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.